December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

31.69 -2.18 (-6.44%)
Official Closing Price Updated: 4:10 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
48 49 Next >
News headline image
Hims & Hers Stock Sinks After-Hours As Weight-Loss Roadmap Gets Clouded — Retail Pounces On The Dip ↗
On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide. 
Via Stocktwits
Topics Earnings
News headline image
What's going on in today's after hours session ↗
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
Hims & Hers Health Stock Drops After Q4 Report: EPS In-Line, Revenues Beat ↗
Hims & Hers Health reports its fourth-quarter results after Monday's closing bell. Here's a look at the key figures from the quarter. 
Via Benzinga
News headline image
Hims & Hers Health (NYSE:HIMS) Beats Q4 Sales Targets But Stock Drops 16%
Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q4 CY2024, with sales up 95.1% year on year to $481.1 million. On top of that, next quarter’s revenue... 
Via StockStory
News headline image
Smart Money Is Betting Big In HIMS Options ↗
 
Via Benzinga
News headline image
Why Hims & Hers Health Stock Is Plummeting Today ↗
Via The Motley Fool
News headline image
Why Novo Nordisk Stock Popped on Friday ↗
Via The Motley Fool
News headline image
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
From Hims & Hers
Via Business Wire
News headline image
What To Expect When IBD 50's No. 2, Hims & Hers, Reports Amid The Semaglutide Battle ↗
Hims & Hers Health is on deck to report its fourth-quarter earnings late Monday. Here's what to expect. 
Via Investor's Business Daily
News headline image
Palantir Extends Losses, Microsoft Slides: What's Driving Markets Monday? ↗
The major indices struggled to maintain early momentum on Monday, but appear to climbing back with the S&P 500 and Dow Jones both green in midday trading.  
Via Benzinga
Topics Stocks
News headline image
Why the growth investor may take a look at NYSE:HIMS. ↗
A fundamental analysis of (NYSE:HIMS): HIMS & HERS HEALTH INC (NYSE:HIMS) showing high EPS and FCF growth while beating expectations 
Via Chartmill
News headline image
Why Hims & Hers Stock Dropped Today ↗
Via The Motley Fool
News headline image
Market Whales and Their Recent Bets on HIMS Options ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 24, 2025 ↗
 
Via Benzinga
News headline image
Why Hims & Hers Health Stock Is Skyrocketing Today ↗
Via The Motley Fool
News headline image
Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide Update ↗
CEO Andrew Dudum acknowledged retail shareholders in a post on X, highlighting their deep research on the company and announcing plans to engage them directly on future earnings calls. 
Via Stocktwits
News headline image
Hims & Hers Health (HIMS) To Report Earnings Tomorrow: Here Is What To Expect
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings tomorrow afternoon. Here’s what investors should know. 
Via StockStory
News headline image
MarketBeat Week in Review – 02/17 - 02/21
Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news 
Via MarketBeat
Topics Economy
News headline image
Don't Call It A Stock Market Crash ↗
A look at what today's price action means from a technical analysis standpoint, and what you can do to be prepared for whatever the stock market throws your way. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Top movers analysis one hour before the close of the markets on 2025-02-21: top gainers and losers in today's session. ↗
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
News headline image
Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 24% in the afternoon session after U.S. Food and Drug Administration (FDA) reported that the shortage of weight-loss drugs such as... 
Via StockStory
Topics Artificial Intelligence
News headline image
Top movers in Friday's session ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
Stocks Firmly Lower As Consumer Sentiment Weakens ↗
The Dow Jones Industrial Average is headed for another sharp triple-digit drop to end the week. 
Via Talk Markets
Topics Stocks Stocks / Equities
News headline image
What's Going On With Hims & Hers Health Stock Today? ↗
Hims & Hers Health acquired a peptide facility to strengthen its U.S. supply chain and meet demand for personalized treatments. Also, in another development, FDA resolves semaglutide injection... 
Via Benzinga
Topics Economy
News headline image
Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage ↗
The FDA said the shortages in Novo Nordisk's weight-loss drug has been resolved. 
Via Investor's Business Daily
News headline image
Hims & Hers Acquires US-based Peptide Facility
From Hims & Hers
Via Business Wire
News headline image
Buy HIMS Stock Here ↗
In this video, I provide my technical analysis for how I would manage the risk and book the profits on the trade. 
Via Talk Markets
Topics Stocks / Equities
News headline image
Hims & Hers Hits New Highs On At-Home Lab Testing Plans: Retail Sees More Room To Run, Analysts Divided ↗
One analyst warned that elevated growth expectations could lead to near-term volatility as the company introduces its FY25 guidance. 
Via Stocktwits
News headline image
Why Is Hims & Hers Health (HIMS) Stock Rocketing Higher Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 24.8% in the afternoon session after the company announced the acquisition of Sigmund (marketed as Trybe Labs), which will allow it to... 
Via StockStory
Topics Artificial Intelligence
News headline image
Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News ↗
The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime. 
Via The Motley Fool
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
48 49 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.